China Pharma Holdings, Inc. (CPHI)
Manufactures injectable and oral medications for treating heart disease, stroke, and infections in China.
$1.13-0.09%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-31.4%
The outlook
China Pharma (CPHI) is trading near the bottom of its 52-week range, sitting well above both its 50- and 200-day moving averages despite minimal daily movement. Analyst coverage appears limited, and the overall neutral sentiment reflects a stock without clear directional conviction from market participants.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range4% of the way from its 52-week low to high
Market cap
$45.6M
52-wk high
$19.19
52-wk low
$0.38
50-day avg
$0.98
200-day avg
$1.07
Trailing P/E
—